An international, phase 2 randomized controlled trial of the dual PPAR alpha-delta agonist GFT505 in adult patients with NASH

作者:Ratziu Vlad; Harrison Stephen A; Francque Sven M; Bedossa Pierre; Serfaty Lawrence; Romero Gomez Manuel; Cales Paul; Abdelmalek M**** F; Caldwell Stephen H; Drenth Joost; Anstee Quentin M; Hum Dean W; Hanf Remy; Roudot Alice; Megnien Sophie; Staels Bart; Sanyal Arun J
来源:66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), 2015-11-13 to 2015-11-17.
  • 出版日期2015-10